116-hr-5982116th Congress

Safe Medicine Act

Sponsored By: Representative Posey, Bill [R-FL-8]

Unknown

Summary

Safe Medicine Act This bill authorizes the Food and Drug Administration to temporarily ban the sale of a drug if (1) the drug (or an active ingredient of the drug) is manufactured in a country that, because of systemic problems of supervision, may be producing contaminated drugs; and (2) the drug's labeling does not have certain warnings about potential contamination. The bill also requires the Department of Health and Human Services to report to Congress on vulnerabilities in the U.S. medicine supply chain, including vulnerabilities related to reliance on production from other countries.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Posey, Bill [R-FL-8]

FL • R

Cosponsors

  • Rep. Ryan, Tim [D-OH-13]

    OH • D

    Sponsored 2/26/2020

  • Rep. Fitzpatrick, Brian K. [R-PA-1]

    PA • R

    Sponsored 3/2/2020

  • Rep. Meadows, Mark [R-NC-11]

    NC • R

    Sponsored 3/2/2020

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation